search
Back to results

Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage

Primary Purpose

Late Postvitrectomy Diabetic Hemorrhage.

Status
Completed
Phase
Not Applicable
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
Cryotherapy
Sponsored by
Shahid Beheshti University of Medical Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Late Postvitrectomy Diabetic Hemorrhage. focused on measuring Rebleeding, Diabetic vitreous hemorrhage, Cryotherapy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Diabetic retinopathy cases undergoing vitrectomy Exclusion Criteria: History of deep vitrectomy or cataract surgery Renal failure Silicone oil injection during surgery Early rebleeding History of antithrombotic drugs usage

Sites / Locations

  • Ophthalmic Research Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

1

2

Arm Description

Cryotherapy

Outcomes

Primary Outcome Measures

Prevention of late vitreous hemorrhage in postvitrectomized diabetic eyes

Secondary Outcome Measures

Incidence of late vitreous hemorrhage in the cryo group.
Incidence of late vitreous hemorrhage in the control group.
Comparing incidence of late vitreous hemorrhage in both groups.

Full Information

First Posted
August 30, 2006
Last Updated
July 31, 2008
Sponsor
Shahid Beheshti University of Medical Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT00370409
Brief Title
Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage
Study Type
Interventional

2. Study Status

Record Verification Date
July 2008
Overall Recruitment Status
Completed
Study Start Date
January 2006 (undefined)
Primary Completion Date
February 2008 (Actual)
Study Completion Date
June 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Shahid Beheshti University of Medical Sciences

4. Oversight

5. Study Description

Brief Summary
Late vitreous hemorrhage in postvitrectomized diabetic eyes may be due to fibrovascular tuft formation in sclerotomy sites. Cryotherapy of sclerotomy sites may prevent bleeding by regressing the fibrovascular tuft. This study will detect the safety and efficacy of cryotherapy of sclerotomy sites for prevention of late vitreous hemorrhage in vitrectomized diabetic eyes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Late Postvitrectomy Diabetic Hemorrhage.
Keywords
Rebleeding, Diabetic vitreous hemorrhage, Cryotherapy

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
112 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Cryotherapy
Arm Title
2
Arm Type
Placebo Comparator
Intervention Type
Procedure
Intervention Name(s)
Cryotherapy
Intervention Description
Cryotherapy of both sides of sclerotomy sites was done for 6 seconds after complition of operation.
Primary Outcome Measure Information:
Title
Prevention of late vitreous hemorrhage in postvitrectomized diabetic eyes
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Incidence of late vitreous hemorrhage in the cryo group.
Time Frame
6 months
Title
Incidence of late vitreous hemorrhage in the control group.
Time Frame
6 months
Title
Comparing incidence of late vitreous hemorrhage in both groups.
Time Frame
6 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diabetic retinopathy cases undergoing vitrectomy Exclusion Criteria: History of deep vitrectomy or cataract surgery Renal failure Silicone oil injection during surgery Early rebleeding History of antithrombotic drugs usage
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Morteza Entezari, MD
Organizational Affiliation
Ophthalmic Research Center of Shaheed Beheshti Medical University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ophthalmic Research Center
City
Tehran
ZIP/Postal Code
16666
Country
Iran, Islamic Republic of

12. IPD Sharing Statement

Learn more about this trial

Cryotherapy of Sclerotomy Sites for Prevention of Late Postvitrectomy Diabetic Hemorrhage

We'll reach out to this number within 24 hrs